DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Myriad Genetics (NASDAQ: MYGN)

37.51 -0.21 (-0.56%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MYGN $37.51 -0.56%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.99
Previous Close $37.72
Daily Range $36.85 - $37.99
52-Week Range $20.02 - $42.50
Market Cap $2.7B
P/E Ratio 16.76
Dividend (Yield) $0.00 (0.0%)
Volume 694,340
Average Daily Volume 873,395
Current FY EPS $1.94

Sector

Services

Industry

Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website: http://www.myriad.com/

News & Commentary

3 Stocks Even Volatility-Loving Nasdaq Investors Hate

The Nasdaq Composite may be hitting a multidecade high, but pessimists are piling into these three Nasdaq-listed stocks. Are things really as bad as these short-interest figures indicate?

Quest Diagnostics Offers A Good Long-Term Opportunity

Myriad Genetics Posts Encouraging myPath Melanoma Data - Analyst Blog

Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed Treatment In 35 % Of Case

Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed Treatment In 35 % Of Cases

Myriad Publishes myRisk Hereditary Cancer Study In Cancer

Update: Myriad Genetics' Patents Are Facing Trouble Again

FuelCell Upgrade; Amazon Announces New Product

FuelCell Upgrade; Amazon Announces New Product

Myriad Genetics' Q4 Earnings Beat Estimates, Revenues Up Y/Y - Analyst Blog

SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

See More MYGN News...

MYGN's Top Competitors

MYGN $37.51 (-0.56%)
Current stock: MYGN
CELG $93.85 (0.62%)
Current stock: CELG
BIIB $329.24 (-0.23%)
Current stock: BIIB
GILD $105.96 (0.03%)
Current stock: GILD